Expanding access to cell and gene therapies with McKesson’s Joe DePinto
Joe DePinto, McKesson’s head of cell and gene advanced therapies, supports patients, providers and payers throughout the treatment journey. He’s particularly passionate about helping patients get access to groundbreaking therapeutic interventions. Maria Whitman gets his perspective on the current s…
ASX 25: Access to Pharmacy in Las Vegas | Part Three sponsored by Lumicera
In part three of our ASX 25 series on pharmacy access in Las Vegas, we expand the conversation to include the national forces, technology advancements, and policy changes influencing how patients access medications in one of America’s fastest-growing healthcare markets.
Sponsored by PrimeRx, this …
Episode 235: Cell and Gene Therapies: The Logistics
Joe DePinto, MBA, Head of Cell, Gene & Advanced Therapies at McKesson, joins the show to discuss InspiroGene, McKesson’s end-to-end platform built to address the complex delivery, coordination, and commercialization needs of cell and gene therapies. He breaks down how InspiroGene integrates logisti…
Trust Matters, Cell and Gene, & World Pharmacists Day | TWIRx
On "This Week in Pharmacy" for September 26th, we're talking about Trust in Healthcare, World Pharmacists Day, and Cell & Gene Therapy.
Today's co-host is Dr. Melissa Smith, PharmD CPH with Florida PGx Consulting LLC. https://www.floridapgxconsulting.com/
First, #TWIRx News - the FDA approves In…
Trust Matters, Cell and Gene, & World Pharmacists Day | TWIRx
On "This Week in Pharmacy" for September 26th, we're talking about Trust in Healthcare, World Pharmacists Day, and Cell & Gene Therapy.
Today's co-host is Dr. Melissa Smith, PharmD CPH with Florida PGx Consulting LLC. https://www.floridapgxconsulting.com/
First, #TWIRx News - the FDA approves In…
The TrumpRx Playbook for Independent Pharmacies - with MatchRX | TWIRx
Up first, Inspirogene-by-McKesson with Joe DePinto
InspiroGene" is a dedicated business unit launched by McKesson in October 2024, focused solely on supporting the commercialization of cell and gene therapies (CGTs). It leverages McKesson's expertise in supply chain, logistics, and specialty phar…
The TrumpRx Playbook for Independent Pharmacies - with MatchRX | TWIRx
Up first, Inspirogene-by-McKesson with Joe DePinto
InspiroGene" is a dedicated business unit launched by McKesson in October 2024, focused solely on supporting the commercialization of cell and gene therapies (CGTs). It leverages McKesson's expertise in supply chain, logistics, and specialty phar…
Joe DePinto: Why advanced therapies need a new delivery model
In this episode of the Ori Spotlight Podcast, Jason C. Foster welcomes Joe DePinto, Head of Cell and Gene Advanced Therapies at McKesson, to explore how advanced therapies can be delivered through the same systems that support other complex medicines.
Joe shares what he has learned from decades of …
Asembia's Specialty Pharmacy Summit 2026 Rewind | Part 2/6
This is the Pharmacy Podcast Network's ASEMBIA 2026 rewind!
We're dedicated to bringing you inside coverage of the pharmacy nation's biggest events with on the street style interviews with keynote speakers, attendees, exhibitors, and recurring guests who make each year special.
This is part two o…
OpenAI’s rogue AI, Trump’s governance diarrhea, EEOC’s Andrea Lucas hates data
Story of the Week (DR):
Trump’s Explosive Diarrhea Scandal Is Getting Worse and Worse
Epidemiological data linked a widespread Cyclospora parasite outbreak—sickening over 1,600 people across multiple states—to shredded iceberg lettuce supplied by Taylor Farms de Mexico, triggering a voluntary 27-…
পডকাস্ট সার্চ ইঞ্জিন
আপনি আমাদের ওয়েবসাইট ব্যবহার করতে পারেন3,820,986পডকাস্ট এবং195,280,751পর্বগুলি মানুষ, স্থান, বা বিষয় দ্বারা অনুসন্ধান করতে৷
জ্ঞানেই বিনিয়োগের সর্বোত্তম ফল মেলে, তাই আমি পডকাস্ট শুনি।
‐ Benjamin "Llamacorn" Franklin
সম্পাদনা
পডকাস্ট ডেটাবেস আপ টু ডেট রাখতে সাহায্য করার জন্য আপনাকে ধন্যবাদ।
